🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Hepatoblastoma

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma NCT04634357Phase 1, Phase 24 sites📍 Los Angeles📍 Orange📍 San Francisco Eureka Therapeutics Inc. · Tests: ET140203 T Cells A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents NCT07300449Phase 22 sites📍 Guangzhou📍 Guangzhou Sun Yat-sen University · Tests: Very low-risk group, Low-risk group, Intermediate-risk group, High-risk group, 5hmc dynamic monitoring Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-CAR.GPC3xIL15.21 CAR T cells Molecular Basis of Pediatric Liver Cancer NCT03959800n/a1 site📍 Pittsburgh University of Pittsburgh B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) NCT04897321Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Fludarabine, Cyclophosphamide, MESNA, B7-H3 CAR T cells A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment NCT04928677Phase 15 sites📍 Los Angeles📍 Atlanta📍 Boston Memorial Sloan Kettering Cancer Center · Tests: Codrituzumab Reduced Intensity Haploidentical BMT for High Risk Solid Tumors NCT01804634Phase 23 sites📍 Baltimore📍 The Bronx📍 Valhalla Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Cyclophosphamide, Fludarabine, low dose total body irradiation, Melphalan, Tacrolimus A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers NCT06541652n/a40 sites📍 Amiens📍 Angers📍 Beauvais Federation Francophone de Cancerologie Digestive Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma NCT04901702Phase 1, Phase 210 sites📍 Palo Alto📍 Aurora📍 Washington D.C. St. Jude Children's Research Hospital · Tests: Onivyde, Talazoparib, Temozolomide A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy NCT04478292Phase 31 site📍 Shanghai Shanghai Children's Medical Center · Tests: Sodium Thiosulfate Injection, Primary surgery resection, mono CDDP-Group A2, Cisplatin, 5-Fluorouracil, Vincristine, Do… Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors NCT04851119Phase 1, Phase 221 sites📍 Birmingham📍 Los Angeles📍 Orange Children's Oncology Group · Tests: Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint, X-Ray Imaging Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies NCT04308330Phase 11 site📍 Valhalla New York Medical College · Tests: Vorinostat Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells NCT06198296Phase 11 site📍 Houston Baylor College of Medicine · Tests: 21.15.GPC3-CAR T cells Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative NCT05556642n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Biospecimen collection Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children NCT07188311NA1 site📍 Guangdong Sun Yat-sen University · Tests: Pucotenlimab ,Lenvatinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy